Super League (Nasdaq: SLE) sells $2.23M, adds room for more stock

Rhea-AI Filing Summary

Super League Enterprise, Inc. (SLE) is amending its prospectus supplement to increase the size of its at-the-market equity program under a Sales Agreement with Benchmark and StoneX. The company has already sold 475,598 shares of common stock for gross proceeds of approximately $2.23 million under this agreement.

Super League now may offer and sell up to an additional $2,270,000 of common stock, separate from the shares previously sold. As of this amendment, the public float is approximately $13,499,954, based on 2,454,537 non‑affiliate shares out of 2,473,171 shares outstanding at a price of $5.50 per share, the highest closing price in the prior 60 days. The company states it remains eligible under General Instruction I.B.6 of Form S-3 and confirms the one‑third public float limitation on primary offerings. SLE’s common stock trades on the Nasdaq Capital Market under the symbol “SLE,” and the last reported sale price on August 21, 2026 was $4.03 per share.

Key Figures

Additional ATM capacity: $2,270,000 Shares sold under Sales Agreement: 475,598 shares Gross proceeds to date: $2.23 million +5 more

8 metrics

Additional ATM capacity $2,270,000 Additional aggregate offering price of common stock available under the Sales Agreement as of this amendment

Shares sold under Sales Agreement 475,598 shares Common stock already sold for gross proceeds of approximately $2.23 million

Gross proceeds to date $2.23 million Aggregate gross proceeds from prior sales under the Sales Agreement

Public float $13,499,954 Value of common stock held by non‑affiliates based on $5.50 per share

Shares held by non-affiliates 2,454,537 shares Non‑affiliate holdings included in public float calculation

Shares outstanding 2,473,171 shares Total common stock outstanding as of the amendment’s reference date

Reference price for float $5.50 per share Highest closing price on Nasdaq Capital Market within prior 60 days, used for float calculation

Last reported sale price $4.03 per share Nasdaq Capital Market closing price on August 21, 2026

Key Terms

prospectus supplement, Sales Agreement, public float, General Instruction I.B.6 of Form S-3, +1 more

5 terms

prospectus supplement regulatory

"to prospectus supplement dated August 18, 2026 (To Prospectus dated December 20, 2024)"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Sales Agreement regulatory

"pursuant to the terms of that certain Sales Agreement (the “Sales Agreement”)"

A sales agreement is a written contract that sets out the terms for selling goods, services, or assets, specifying price, delivery, payment schedule and responsibilities of each side. For investors it matters because it creates a predictable stream of revenue or cash obligations, clarifies timing and risk, and can change a company’s value or forecasts much like a signed order turns a customer’s verbal intent into a firm commitment.

public float financial

"the aggregate market value of our outstanding Common Stock held by non-affiliates, or our public float"

Public float is the total number of a company's shares that are available for trading by the general public. It excludes shares held by company insiders or large stakeholders who are unlikely to sell them easily. This figure helps investors understand how much of the company's stock is actively available, which can influence its liquidity and how easily its price might change.

General Instruction I.B.6 of Form S-3 regulatory

"We have sold no securities pursuant to General Instruction I.B.6 of Form S-3"

Nasdaq Capital Market market

"which is the highest closing price of our Common Stock on The Nasdaq Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

Offering Details

ATM

Offering

Offering Type ATM

FAQ

What is Super League Enterprise, Inc. (SLE) offering in this 424B5 amendment?

Super League Enterprise, Inc. may sell up to an additional $2,270,000 of its common stock under an existing Sales Agreement with Benchmark and StoneX, in addition to shares previously sold, as part of an at-the-market offering program under its Form S-3 shelf registration.

How much stock has SLE already sold under the Sales Agreement?

Super League has already sold 475,598 shares of common stock for gross proceeds of approximately $2.23 million pursuant to the Sales Agreement referenced in the prospectus supplement and this amendment.

What is SLE’s current public float and share count?

The public float is approximately $13,499,954, based on 2,454,537 shares of common stock held by non‑affiliates out of 2,473,171 shares outstanding, at a reference price of $5.50 per share as of August 18, 2026.

How does Form S-3 General Instruction I.B.6 limit SLE’s offering size?

Super League states it is eligible under General Instruction I.B.6 of Form S-3, which limits public primary offerings to no more than one-third of public float in any 12‑month period while float remains below $75.0 million.

At what prices has SLE’s stock recently traded according to the amendment?

The amendment cites a $5.50 per share closing price on August 18, 2026, used to calculate public float, and a last reported sale price of $4.03 per share on August 21, 2026 on the Nasdaq Capital Market.

What are the risks mentioned for investing in SLE’s common stock?

The company states that investing in its common stock involves significant risks and directs investors to the “Risk Factors” sections in the prospectus supplement, the accompanying prospectus, and incorporated documents for detailed discussion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 06:03 AM Accepted by SEC EDGAR 08/21/2026 - 09:41 PM Learn about SEC filing dates

Filed pursuant to Rule 424(b)(5)

Registration No. 333-283812

AMENDMENT NO. 1 DATED AUGUST 21, 2026

TO PROSPECTUS SUPPLEMENT DATED AUGUST 18, 2026

(To Prospectus dated December 20, 2024)

Super League Enterprise, Inc.

UP TO $2,270,000

COMMON STOCK

This Amendment No. 1 to prospectus supplement (“Amendment No. 1”) amends and supplements the information in the supplements the information in the prospectus, dated December 20, 2024, filed as part of our registration statement on Form S-3 (File No. 333-283812), as supplemented by our propspectus supplement dated August 18, 2026 (collectively, the “Prior Prospectuses”). This Amendment No. 1  should be read in conjunction with the Prior Prospectuses, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This Amendment No. 1 is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectuses, and any future amendments or supplements thereto.

We filed the Prior Prospectuses to register the offer and sale of our common stock, par value $0.001 per share (the “Common Stock”), from time to time pursuant to the terms of that certain Sales Agreement (the “Sales Agreement”) with The Benchmark Company, LLC (“Benchmark”) and StoneX Financial Inc. (“StoneX” and, together with Benchmark, the “Agents”), dated August 18, 2026. 

Since our entry into the Sales Agreement, we have offered and sold an aggregate of 475,598 shares of common stock for gross proceeds of approximately $2.23 million pursuant to the Sales Agreement.

We are filing this Amendment No. 1 to supplement the Prior Prospectuses to increase the aggregate amount we intend to sell pursuant to the Sales Agreement. As of the date of this Amendment No. 1, we are offering up to an additional $2,270,000 of our Common Stock for sale under the Sales Agreement, not including the shares of Common Stock previously sold pursuant to the Sales Agreement.

The terms “Company,” “we,” “us” and “our” refer to Super League Enterprise, Inc., a Delaware corporation.

As of the date of this Amendment No. 1, the aggregate market value of our outstanding Common Stock held by non-affiliates, or our public float, was approximately $13,499,954based on a total number of 2,473,171 shares of Common Stock held outstanding, or which 2,454,537 share of Common Stock were held by non-affiliates, at a price of $5.50 per share, the closing price of our Common Stock on August 18, 2026, which is the highest closing price of our Common Stock on The Nasdaq Capital Market within the prior 60 days.  We have sold no securities pursuant to General Instruction I.B.6 of Form S-3 during the 12 calendar months prior to and including the date of this prospectus supplement (excluding this offering). Accordingly, based on the foregoing, we are currently eligible under General Instruction I.B.6 of Form S-3 to offer and sell additional shares of our Common Stock having an aggregate offering price of up to approximately $2,270,000. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding one-third of our public float in any 12-month period so long as our public float remains below $75.0 million.

Our Common Stock is traded on the Nasdaq Capital Market under the symbol “SLE.” On August 21, 2026, the last reported sale price of our Common Stock as reported on the Nasdaq Capital Market was $4.03 per share.

Investing in our Common Stock involves significant risks. Please read the information under the heading “Risk Factors” on page S-4 of the Prospectus Supplement, on page 5 of the accompanying prospectus and under similar headings in other documents incorporated by reference into the Prospectus Supplement and the accompanying prospectus before making a decision to invest in our Common Stock.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities, or determined if this prospectus supplement or the accompanying prospectus is accurate or complete. Any representation to the contrary is a criminal offense.

Joint Placement Agents

Benchmark, a StoneX company StoneX Financial Inc.

The date of this prospectus supplement is August 21, 2026.